Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1994 5
1996 1
1997 3
1998 3
1999 8
2000 9
2001 4
2002 10
2003 7
2004 11
2005 13
2006 19
2007 47
2008 53
2009 56
2010 88
2011 83
2012 106
2013 121
2014 119
2015 135
2016 178
2017 159
2018 146
2019 128
2020 114
2021 133
Text availability
Article attribute
Article type
Publication date

Search Results

1,558 results
Results by year
Filters applied: . Clear all
Page 1
Comparative Pharmacology of Risperidone and Paliperidone.
Corena-McLeod M. Corena-McLeod M. Drugs R D. 2015 Jun;15(2):163-74. doi: 10.1007/s40268-015-0092-x. Drugs R D. 2015. PMID: 25943458 Free PMC article. Review.
This review seeks to explore the most significant differences at the molecular level between risperidone and paliperidone, as reported in preclinical studies. Although risperidone shows higher affinity for 5-HT receptors, paliperidone does not fit this profile. Thus …
This review seeks to explore the most significant differences at the molecular level between risperidone and paliperidone, as reporte …
Paliperidone palmitate: effectiveness, safety, and the use for treatment of schizophrenia.
Jarema M, Bieńkowski P, Heitzman J, Parnowski T, Rybakowski J. Jarema M, et al. Psychiatr Pol. 2017 Feb 26;51(1):7-21. doi: 10.12740/PP/64581. Epub 2017 Feb 26. Psychiatr Pol. 2017. PMID: 28455891 Free article. Review. English, Polish.
The aim of the study was to summarize the efficacy and tolerability of paliperidone palmitate, an atypical long-acting antipsychotic drug. Paliperidone is a 9-hydroxy metabolite of risperidone with a slightly different receptor profile and significantly different ph …
The aim of the study was to summarize the efficacy and tolerability of paliperidone palmitate, an atypical long-acting antipsychotic …
Paliperidone.
[No authors listed] [No authors listed] 2021 Aug 16. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. 2021 Aug 16. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. PMID: 30000552 Free Books & Documents. Review.
Although no data are available for the use of paliperidone during breastfeeding, it is the active metabolite of risperidone. ...Because paliperidone is available only as a sustained-release product, timing of nursing with respect to doses would not be useful....
Although no data are available for the use of paliperidone during breastfeeding, it is the active metabolite of risperidone. ...Becau …
Paliperidone for the treatment of schizoaffective disorder.
Alphs L, Fu DJ, Turkoz I. Alphs L, et al. Expert Opin Pharmacother. 2016;17(6):871-83. doi: 10.1517/14656566.2016.1161029. Epub 2016 Mar 24. Expert Opin Pharmacother. 2016. PMID: 26934062 Review.
AREAS COVERED: Data from 3 pivotal studies evaluating the acute and maintenance treatment of SCA with paliperidone are reviewed. Two formulations of paliperidone have been studied for these indications: an extended-release oral formulation (NCT00397033, NCT00412373) …
AREAS COVERED: Data from 3 pivotal studies evaluating the acute and maintenance treatment of SCA with paliperidone are reviewed. Two …
Paliperidone.
[No authors listed] [No authors listed] 2016 Mar 10. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2016 Mar 10. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643825 Free Books & Documents. Review.
Paliperidone is a second generation (atypical) antipsychotic agent that is available in both oral and long acting parenteral forms and is used in the treatment of schizophrenia. Paliperidone is associated with a low rate of serum aminotransferase elevations during t
Paliperidone is a second generation (atypical) antipsychotic agent that is available in both oral and long acting parenteral forms an
Paliperidone palmitate versus oral antipsychotics in recently diagnosed schizophrenia.
Schreiner A, Aadamsoo K, Altamura AC, Franco M, Gorwood P, Neznanov NG, Schronen J, Ucok A, Zink M, Janik A, Cherubin P, Lahaye M, Hargarter L. Schreiner A, et al. Schizophr Res. 2015 Dec;169(1-3):393-399. doi: 10.1016/j.schres.2015.08.015. Epub 2015 Oct 1. Schizophr Res. 2015. PMID: 26431793 Free article. Clinical Trial.
This randomized controlled study assessed the efficacy of paliperidone palmitate versus oral antipsychotics for relapse prevention. ...For paliperidone palmitate, a significantly greater improvement in Positive and Negative Syndrome Scale total score on Day 8 (P=0.0 …
This randomized controlled study assessed the efficacy of paliperidone palmitate versus oral antipsychotics for relapse prevention. . …
Long-Acting Injectable Paliperidone Palmitate: A Review of Efficacy and Safety.
Morris MT, Tarpada SP. Morris MT, et al. Psychopharmacol Bull. 2017 May 15;47(2):42-52. Psychopharmacol Bull. 2017. PMID: 28626271 Free PMC article. Review.
OBJECTIVE: Summarize and synthesize the current literature regarding long-acting injectable paliperidone palmitate for the treatment of schizophrenia. METHODS: A literature search of PubMed, Embase, and Web of Science was conducted in February 2016, using the following sea …
OBJECTIVE: Summarize and synthesize the current literature regarding long-acting injectable paliperidone palmitate for the treatment …
The preclinical discovery and development of paliperidone for the treatment of schizophrenia.
Wesołowska A, Jastrzębska-Więsek M, Cios A, Partyka A. Wesołowska A, et al. Expert Opin Drug Discov. 2020 Mar;15(3):279-292. doi: 10.1080/17460441.2020.1682994. Epub 2019 Oct 29. Expert Opin Drug Discov. 2020. PMID: 31661992 Review.
It is recommended in patients with hepatic impairment and evokes less drug-drug interactions.Areas covered: This review article focuses on the preclinical discovery of paliperidone, the major active metabolite of risperidone. It provides details regarding paliperidone
It is recommended in patients with hepatic impairment and evokes less drug-drug interactions.Areas covered: This review article focuses on t …
Personalizing dosing of risperidone, paliperidone and clozapine using therapeutic drug monitoring and pharmacogenetics.
de Leon J. de Leon J. Neuropharmacology. 2020 May 15;168:107656. doi: 10.1016/j.neuropharm.2019.05.033. Epub 2019 May 28. Neuropharmacology. 2020. PMID: 31150659 Review.
Once-a-month long-acting paliperidone provides a C/D ratio around 7.7 ng/ml per mg/day at steady state, which is expected to be in the 8th month (before the 9th injection). TDM is particularly important for long-acting paliperidone formulations that may accumulate o …
Once-a-month long-acting paliperidone provides a C/D ratio around 7.7 ng/ml per mg/day at steady state, which is expected to be in th …
Paliperidone extended-release in the short- and long-term treatment of schizophrenia.
Valsecchi P, Garozzo A, Nibbio G, Barlati S, Deste G, Turrina C, Sacchetti E, Vita A. Valsecchi P, et al. Riv Psichiatr. 2019 Mar-Apr;54(2):43-58. doi: 10.1708/3142.31245. Riv Psichiatr. 2019. PMID: 30985829 Review.
Paliperidone is a second-generation antipsychotic drug belonging to the class of benzisoxasole derivatives. ...However, due to its peculiar characteristics, paliperidone may be particularly useful in the treatment of schizophrenic patients. ...
Paliperidone is a second-generation antipsychotic drug belonging to the class of benzisoxasole derivatives. ...However, due to its pe
1,558 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page